Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hypo-A is a German healthcare company specializing in orthomolecular medicine and high-quality nutritional supplements. Founded by Peter-Hansen Volkmann, the company focuses on producing pure supplements that are free from common allergens and additives such as magnesium stearate, lactose, and gluten. Their product portfolio includes vitamins, minerals, trace elements, and probiotics designed to support metabolic health and the immune system. Hypo-A emphasizes the importance of bioavailability and the synergy of natural ingredients to address chronic conditions and nutritional deficiencies. The company primarily serves the European market through medical practitioners and direct sales.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hypo-A.